ProQR Therapeutics N.V. (PRQR)

NASDAQ: PRQR · IEX Real-Time Price · USD

1.645

-0.005 (-0.30%)

At close: Jul 2, 2024, 4:00 PM

1.650

+0.005 (0.30%)

After-hours: Jul 2, 2024, 4:09 PM EDT

ProQR Therapeutics Cash Flow Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2013
Net Income	-28.12	-64.42	-60.74	-46.57	-56.48	Upgrade
Depreciation & Amortization	2.51	2.52	2.33	2.36	2.05	Upgrade
Share-Based Compensation	3.11	2.87	6.22	7.84	9.11	Upgrade
Other Operating Activities	44.05	-9.47	26.18	-9.7	0.73	Upgrade
Operating Cash Flow	21.55	-68.51	-26.01	-46.07	-44.59	Upgrade
Capital Expenditures	6.63	-0.7	-0.43	-0.92	-0.58	Upgrade
Other Investing Activities	-2.35	-	-	-	-	Upgrade
Investing Cash Flow	4.28	-0.7	-0.43	-0.92	-0.58	Upgrade
Share Issuance / Repurchase	0.35	14.16	110	0.74	48.74	Upgrade
Debt Issued / Paid	-2.63	-45.05	26.84	13.77	1.46	Upgrade
Financing Cash Flow	-2.28	-30.89	136.83	14.5	50.2	Upgrade
Exchange Rate Effect	0.6	7.35	1.29	-2.63	0.72	Upgrade
Net Cash Flow	23.55	-100.1	110.4	-33.48	5.65	Upgrade
Free Cash Flow	28.18	-69.21	-26.44	-47	-45.17	Upgrade
Free Cash Flow Margin	295.82%	-1587.75%	-1111.73%	-497.21%	-2336.83%	Upgrade
Free Cash Flow Per Share	0.35	-0.97	-0.41	-0.94	-1.10	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).